Replies to post #120031 on Biotech Values

[DFRAI]

DAveAu

Thanks for the explanation. I believe the ceo covered the delays at the last AGM somewhat.

I would expect more confidence building with the lung and pancreatic phase II results that are forthcoming in the next 1-4 months.

[DewDiligence]

ONCY—I believe the point was that time to progression could be used as a proxy for overall survival…

Why would a reputable company think it was necessary to state the obvious? I’m inclined to agree with iwfal on this specific point.

p.s. Welcome to the board.